What did @its.that.girl.tash actually say?
The creator says she stopped using a dermatologist-prescribed pigmentation cream because she was concerned it was thinning her skin and increasing sun sensitivity. Instead, she was taking GHK-Cu (which she calls "Judge Ksu") daily and glutathione 200mg three times per week. When she came clean to her dermatologist about this, she says her derm not only approved but admitted to taking glutathione herself, calling it "super effective in fading pigmentation." The derm also apparently noted that certain ethnic groups, including Greek, Italian, and Indian people, are more susceptible to pigmentation and may benefit more from glutathione. The creator also claims GHK-Cu helps speed up healing of post-acne marks.
She's describing a real-world clinical interaction, not a manufacturer's pitch. That's worth noting. But "my derm takes it too" is not the same as a controlled trial.
Does the science back this up?
There is legitimate evidence behind both ingredients, though the quality and context matters significantly. The claims aren't invented, but they are selectively optimistic.
Glutathione's role in skin lightening has been studied, primarily in Asian populations. A 2012 randomised controlled trial by Arjinpathana and Asawanonda in the Journal of Dermatological Treatment found oral glutathione (500mg daily) produced measurable skin lightening over 4 weeks. A 2017 review in the Journal of Clinical and Aesthetic Dermatology (Sonthalia et al.) confirmed the mechanism: glutathione inhibits eumelanin synthesis by scavenging free radicals and directly inhibiting tyrosinase. The doses studied are generally 250-500mg daily, so 200mg three times weekly sits below typical trial dosing. Whether that's enough to be effective is genuinely unclear.
GHK-Cu (copper peptide) has stronger evidence for wound healing and collagen stimulation than for direct pigmentation reduction. Pickart et al. have published extensively on GHK-Cu's role in skin remodelling since the 1990s. Its application to post-inflammatory hyperpigmentation is plausible mechanistically but undersupported by robust human RCT data specifically targeting pigmentation outcomes.
What did they get wrong (or right)?
Credit where it's due: her concern about the prescription cream thinning her skin is legitimate. Many topical pigmentation treatments contain corticosteroids or tretinoin, which can cause epidermal thinning and increased photosensitivity with prolonged use. That's a real side effect, not fearmongering.
The claim that glutathione is "super effective" is overstated relative to the evidence. The studies show modest, measurable effects, not dramatic transformations. Most trial participants weren't assessed beyond 12 weeks.
The claim that certain ethnicities benefit more from glutathione is interesting and not baseless. Fitzpatrick skin type IV-VI populations produce more eumelanin, which glutathione preferentially shifts toward phaeomelanin. But the creator frames this as her dermatologist's offhand comment, not a clinically established protocol, and it shouldn't be treated as one.
The 200mg three-times-weekly dose she describes is lower than virtually every studied protocol. She should not interpret her results as proof the dose is optimal.
What should you actually know?
Both GHK-Cu and oral glutathione have legitimate scientific interest behind them. Neither is a proven, approved treatment for hyperpigmentation in the way that, for example, topical hydroquinone or azelaic acid are. That gap matters if you're making decisions.
Oral glutathione's bioavailability has also been contested. A 2015 study by Richie et al. in the European Journal of Nutrition showed sustained oral supplementation does increase tissue glutathione levels, which addressed some earlier scepticism, but absorption varies significantly by formulation and individual gut health.
GHK-Cu applied topically or used systemically shows genuine promise for skin repair and may support faster resolution of post-inflammatory marks, as the creator claims. But calling it a pigmentation treatment specifically is getting ahead of the current evidence base.
Finally, the creator casually mentions hoping these compounds become more widely available on the "grain market" (presumably grey or general market). Both are currently sold as research compounds or in compounded formulations in many countries. Regulatory status varies. Anyone considering these should be working with a licensed provider, not sourcing independently based on a TikTok recommendation, however well-intentioned.